Insider · CIK 0001805624
Glendon E. French III
directorceopresidentofficer
Files at LUNG (Pulmonx Corp). First filing Oct 21, 2024, latest Sep 3, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $1.0M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LUNG: Pulmonx Corp
LUNGOct 9, 2026 · close 1.84
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Pulmonx Corp | $95k 41,882 shares | -4% | +91% from low-14% from high | |
| 40Moderate | Pulmonx Corp | $14k 8,805 shares | -3% | +34% from low-81% from high | |
| 6Weak | Pulmonx Corp | $157k 20,000 shares | -2% | - | |
| 20Weak | Pulmonx Corp | $459k 55,453 shares | -5% | - | |
| 0Weak | Pulmonx Corp | $30k 4,547 shares | -0% | - | |
| 21Weak | Pulmonx Corp | $133k 20,000 shares | -2% | - | |
| 6Weak | Pulmonx Corp | $130k 20,000 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | LUNG Pulmonx Corp | SOpen-market sale Common Stock | -4,098 | $2.26 | $9,261 | 1,175,720 | 39 d ago |
| Sep 1, 2026 | LUNG Pulmonx Corp | SOpen-market sale Common Stock | -37,784 | $2.26 | $85k | 1,137,936 | 39 d ago |
| Dec 1, 2025 | LUNG Pulmonx Corp | SOpen-market sale Common Stock | -2,524 | $1.57 | $3,963 | 283,605 | Dec 3, 2025 |
| Dec 1, 2025 | LUNG Pulmonx Corp | SOpen-market sale Common Stock | -6,281 | $1.57 | $9,861 | 277,324 | Dec 3, 2025 |
| Dec 1, 2025 | LUNG Pulmonx Corp | AGrant or award Common Stock | +1,200,000 | $0.00 | $0 | 1,477,324 | Dec 3, 2025 |
| Dec 1, 2025 | LUNG Pulmonx Corp | AGrant or award Performance Stock Unitsderivative | +800,000 | $0.00 | $0 | 800,000 | Dec 3, 2025 |
| Jun 2, 2025 | LUNG Pulmonx Corp | AGrant or award Common Stock | +37,153 | $0.00 | $0 | 1,029,127 | Jun 4, 2025 |
| Mar 20, 2025 | LUNG Pulmonx Corp | SOpen-market sale Common Stock10b5-1 | -20,000 | $7.85 | $157k | 991,974 | Mar 21, 2025 |
| Feb 20, 2025 | LUNG Pulmonx Corp | SOpen-market sale Common Stock10b5-1 | -43,036 | $8.14 | $350k | 1,024,391 | Feb 24, 2025 |
| Feb 20, 2025 | LUNG Pulmonx Corp | SOpen-market sale Common Stock10b5-1 | -12,417 | $8.76 | $109k | 1,011,974 | Feb 24, 2025 |
| Jan 16, 2025 | LUNG Pulmonx Corp | SOpen-market sale Common Stock10b5-1 | -2,326 | $6.53 | $15k | 1,069,648 | Jan 21, 2025 |
| Jan 17, 2025 | LUNG Pulmonx Corp | SOpen-market sale Common Stock10b5-1 | -2,221 | $6.50 | $14k | 1,067,427 | Jan 21, 2025 |
| Nov 22, 2024 | LUNG Pulmonx Corp | SOpen-market sale Common Stock10b5-1 | -20,000 | $6.63 | $133k | 1,071,974 | Nov 26, 2024 |
| Oct 17, 2024 | LUNG Pulmonx Corp | SOpen-market sale Common Stock10b5-1 | -20,000 | $6.52 | $130k | 1,091,974 | Oct 21, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.